<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>GSK ownership changes · Brandtree</title><link>https://brandtree.site/company/gsk</link><atom:link href="https://brandtree.site/company/gsk/feed.xml" rel="self" type="application/rss+xml"/><description>Acquisitions, divestitures and ownership changes involving GSK.</description><item><title>Spin-off: Haleon — Sensodyne, Panadol, Voltaren, Centrum, Advil, Polident, Otrivin and Parodontax</title><link>https://brandtree.site/deal/gsk-demerges-haleon-2022</link><guid>https://brandtree.site/deal/gsk-demerges-haleon-2022</guid><pubDate>Mon, 18 Jul 2022 00:00:00 GMT</pubDate><description>GSK demerged its consumer healthcare business as Haleon, listing it in London and New York in July 2022. The business already contained Pfizer's consumer health portfolio, contributed to a joint venture in 2019, which is how Advil and Centrum came to sit alongside Sensodyne and Panadol.</description></item></channel></rss>